Target Gene/Pathway Pathway / Gene


Search results


No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Adherens junction 💬
1件: IGF1R 💬 Linsitinib 💬 Linsitinib 1件: 232 💬
2 Adherens junction 💬
1件: IGF1R 💬 Mecasermin 💬 Mecasermin 4件: 96, 168, 265, 299 💬
3 Adherens junction 💬
1件: IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin 4件: 96, 168, 265, 299 💬
4 AMPK signaling pathway 💬
1件: IGF1R 💬 Linsitinib 💬 Linsitinib 1件: 232 💬
5 AMPK signaling pathway 💬
1件: IGF1R 💬 Mecasermin 💬 Mecasermin 4件: 96, 168, 265, 299 💬
6 AMPK signaling pathway 💬
1件: IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin 4件: 96, 168, 265, 299 💬
7 Autophagy - animal 💬
1件: IGF1R 💬 Linsitinib 💬 Linsitinib 1件: 232 💬
8 Autophagy - animal 💬
1件: IGF1R 💬 Mecasermin 💬 Mecasermin 4件: 96, 168, 265, 299 💬
9 Autophagy - animal 💬
1件: IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin 4件: 96, 168, 265, 299 💬
10 Breast cancer 💬
1件: IGF1R 💬 Linsitinib 💬 Linsitinib 1件: 232 💬
11 Breast cancer 💬
1件: IGF1R 💬 Mecasermin 💬 Mecasermin 4件: 96, 168, 265, 299 💬
12 Breast cancer 💬
1件: IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin 4件: 96, 168, 265, 299 💬
13 Endocytosis 💬
1件: IGF1R 💬 Linsitinib 💬 Linsitinib 1件: 232 💬
14 Endocytosis 💬
1件: IGF1R 💬 Mecasermin 💬 Mecasermin 4件: 96, 168, 265, 299 💬
15 Endocytosis 💬
1件: IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin 4件: 96, 168, 265, 299 💬
16 Focal adhesion 💬
1件: IGF1R 💬 Linsitinib 💬 Linsitinib 1件: 232 💬
17 Focal adhesion 💬
1件: IGF1R 💬 Mecasermin 💬 Mecasermin 4件: 96, 168, 265, 299 💬
18 Focal adhesion 💬
1件: IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin 4件: 96, 168, 265, 299 💬
19 FoxO signaling pathway 💬
1件: IGF1R 💬 Linsitinib 💬 Linsitinib 1件: 232 💬
20 FoxO signaling pathway 💬
1件: IGF1R 💬 Mecasermin 💬 Mecasermin 4件: 96, 168, 265, 299 💬
21 FoxO signaling pathway 💬
1件: IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin 4件: 96, 168, 265, 299 💬
22 Glioma 💬
1件: IGF1R 💬 Linsitinib 💬 Linsitinib 1件: 232 💬
23 Glioma 💬
1件: IGF1R 💬 Mecasermin 💬 Mecasermin 4件: 96, 168, 265, 299 💬
24 Glioma 💬
1件: IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin 4件: 96, 168, 265, 299 💬
25 Hepatocellular carcinoma 💬
1件: IGF1R 💬 Linsitinib 💬 Linsitinib 1件: 232 💬
26 Hepatocellular carcinoma 💬
1件: IGF1R 💬 Mecasermin 💬 Mecasermin 4件: 96, 168, 265, 299 💬
27 Hepatocellular carcinoma 💬
1件: IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin 4件: 96, 168, 265, 299 💬
28 HIF-1 signaling pathway 💬
1件: IGF1R 💬 Linsitinib 💬 Linsitinib 1件: 232 💬
29 HIF-1 signaling pathway 💬
1件: IGF1R 💬 Mecasermin 💬 Mecasermin 4件: 96, 168, 265, 299 💬
30 HIF-1 signaling pathway 💬
1件: IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin 4件: 96, 168, 265, 299 💬
31 Hormone signaling 💬
1件: IGF1R 💬 Linsitinib 💬 Linsitinib 1件: 232 💬
32 Hormone signaling 💬
1件: IGF1R 💬 Mecasermin 💬 Mecasermin 4件: 96, 168, 265, 299 💬
33 Hormone signaling 💬
1件: IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin 4件: 96, 168, 265, 299 💬
34 Long-term depression 💬
1件: IGF1R 💬 Linsitinib 💬 Linsitinib 1件: 232 💬
35 Long-term depression 💬
1件: IGF1R 💬 Mecasermin 💬 Mecasermin 4件: 96, 168, 265, 299 💬
36 Long-term depression 💬
1件: IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin 4件: 96, 168, 265, 299 💬
37 Longevity regulating pathway 💬
1件: IGF1R 💬 Linsitinib 💬 Linsitinib 1件: 232 💬
38 Longevity regulating pathway 💬
1件: IGF1R 💬 Mecasermin 💬 Mecasermin 4件: 96, 168, 265, 299 💬
39 Longevity regulating pathway 💬
1件: IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin 4件: 96, 168, 265, 299 💬
40 Longevity regulating pathway - multiple species 💬
1件: IGF1R 💬 Linsitinib 💬 Linsitinib 1件: 232 💬
41 Longevity regulating pathway - multiple species 💬
1件: IGF1R 💬 Mecasermin 💬 Mecasermin 4件: 96, 168, 265, 299 💬
42 Longevity regulating pathway - multiple species 💬
1件: IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin 4件: 96, 168, 265, 299 💬
43 MAPK signaling pathway 💬
1件: IGF1R 💬 Linsitinib 💬 Linsitinib 1件: 232 💬
44 MAPK signaling pathway 💬
1件: IGF1R 💬 Mecasermin 💬 Mecasermin 4件: 96, 168, 265, 299 💬
45 MAPK signaling pathway 💬
1件: IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin 4件: 96, 168, 265, 299 💬
46 Melanoma 💬
1件: IGF1R 💬 Linsitinib 💬 Linsitinib 1件: 232 💬
47 Melanoma 💬
1件: IGF1R 💬 Mecasermin 💬 Mecasermin 4件: 96, 168, 265, 299 💬
48 Melanoma 💬
1件: IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin 4件: 96, 168, 265, 299 💬
49 mTOR signaling pathway 💬
1件: IGF1R 💬 Linsitinib 💬 Linsitinib 1件: 232 💬
50 mTOR signaling pathway 💬
1件: IGF1R 💬 Mecasermin 💬 Mecasermin 4件: 96, 168, 265, 299 💬
51 mTOR signaling pathway 💬
1件: IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin 4件: 96, 168, 265, 299 💬
52 Oocyte meiosis 💬
1件: IGF1R 💬 Linsitinib 💬 Linsitinib 1件: 232 💬
53 Oocyte meiosis 💬
1件: IGF1R 💬 Mecasermin 💬 Mecasermin 4件: 96, 168, 265, 299 💬
54 Oocyte meiosis 💬
1件: IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin 4件: 96, 168, 265, 299 💬
55 Ovarian steroidogenesis 💬
1件: IGF1R 💬 Linsitinib 💬 Linsitinib 1件: 232 💬
56 Ovarian steroidogenesis 💬
1件: IGF1R 💬 Mecasermin 💬 Mecasermin 4件: 96, 168, 265, 299 💬
57 Ovarian steroidogenesis 💬
1件: IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin 4件: 96, 168, 265, 299 💬
58 Pathways in cancer 💬
1件: IGF1R 💬 Linsitinib 💬 Linsitinib 1件: 232 💬
59 Pathways in cancer 💬
1件: IGF1R 💬 Mecasermin 💬 Mecasermin 4件: 96, 168, 265, 299 💬
60 Pathways in cancer 💬
1件: IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin 4件: 96, 168, 265, 299 💬
61 PI3K-Akt signaling pathway 💬
1件: IGF1R 💬 Linsitinib 💬 Linsitinib 1件: 232 💬
62 PI3K-Akt signaling pathway 💬
1件: IGF1R 💬 Mecasermin 💬 Mecasermin 4件: 96, 168, 265, 299 💬
63 PI3K-Akt signaling pathway 💬
1件: IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin 4件: 96, 168, 265, 299 💬
64 Progesterone-mediated oocyte maturation 💬
1件: IGF1R 💬 Linsitinib 💬 Linsitinib 1件: 232 💬
65 Progesterone-mediated oocyte maturation 💬
1件: IGF1R 💬 Mecasermin 💬 Mecasermin 4件: 96, 168, 265, 299 💬
66 Progesterone-mediated oocyte maturation 💬
1件: IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin 4件: 96, 168, 265, 299 💬
67 Prostate cancer 💬
1件: IGF1R 💬 Linsitinib 💬 Linsitinib 1件: 232 💬
68 Prostate cancer 💬
1件: IGF1R 💬 Mecasermin 💬 Mecasermin 4件: 96, 168, 265, 299 💬
69 Prostate cancer 💬
1件: IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin 4件: 96, 168, 265, 299 💬
70 Proteoglycans in cancer 💬
1件: IGF1R 💬 Linsitinib 💬 Linsitinib 1件: 232 💬
71 Proteoglycans in cancer 💬
1件: IGF1R 💬 Mecasermin 💬 Mecasermin 4件: 96, 168, 265, 299 💬
72 Proteoglycans in cancer 💬
1件: IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin 4件: 96, 168, 265, 299 💬
73 Rap1 signaling pathway 💬
1件: IGF1R 💬 Linsitinib 💬 Linsitinib 1件: 232 💬
74 Rap1 signaling pathway 💬
1件: IGF1R 💬 Mecasermin 💬 Mecasermin 4件: 96, 168, 265, 299 💬
75 Rap1 signaling pathway 💬
1件: IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin 4件: 96, 168, 265, 299 💬
76 Ras signaling pathway 💬
1件: IGF1R 💬 Linsitinib 💬 Linsitinib 1件: 232 💬
77 Ras signaling pathway 💬
1件: IGF1R 💬 Mecasermin 💬 Mecasermin 4件: 96, 168, 265, 299 💬
78 Ras signaling pathway 💬
1件: IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin 4件: 96, 168, 265, 299 💬
79 Signaling pathways regulating pluripotency of stem cells 💬
1件: IGF1R 💬 Linsitinib 💬 Linsitinib 1件: 232 💬
80 Signaling pathways regulating pluripotency of stem cells 💬
1件: IGF1R 💬 Mecasermin 💬 Mecasermin 4件: 96, 168, 265, 299 💬
81 Signaling pathways regulating pluripotency of stem cells 💬
1件: IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin 4件: 96, 168, 265, 299 💬
82 Transcriptional misregulation in cancer 💬
1件: IGF1R 💬 Linsitinib 💬 Linsitinib 1件: 232 💬
83 Transcriptional misregulation in cancer 💬
1件: IGF1R 💬 Mecasermin 💬 Mecasermin 4件: 96, 168, 265, 299 💬
84 Transcriptional misregulation in cancer 💬
1件: IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin 4件: 96, 168, 265, 299 💬